Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 22, 2011
Patent Application Number
12436925
Date Filed
May 7, 2009
Patent Primary Examiner
Patent abstract
The present invention provides antibodies that bind human CXCR4 and are characterized as having high affinity and strong neutralizing properties. The antibodies of the invention are useful in the treatment of tumorigenesis, including tumor growth, invasion, angiogenesis, or metastasis.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
